
Women’s health clinical trials: breaking down barriers through decentralisation
Women tend to be harder to recruit for clinical trials due to socioeconomic factors. But decentralised study designs help ease…
ByWomen tend to be harder to recruit for clinical trials due to socioeconomic factors. But decentralised study designs help ease…
ByMarcin Stefanowicz, Regional Study Manager, Roche, explains why the advent of mobile health technology should be embraced in clinical research
CTA Editor Henry Kerali explores what impact blockchain could have on clinical research
Edit Kovalcsik, PhD, Managing Analyst, GlobalData, explores AstraZeneca’s plans to enter into the Chinese health care space
CTA’s Anne-Marie Mongan unpacks the tangible benefits of going virtual
Anthony Zuccarello, Associate Director, IRT and Global Clinical Supply Strategy, Amicus Therapeutics, offers insight on how to create efficiencies within…
Clive E. Badman, OBE, talks to CTA’s Charlie Abrines about the digitization of the clinical supply chain
Guillaume Trusz, CTA Contributor, discusses the quite recent approval of the 7T MRI and its upcoming role within the clinical…
Thank you for subscribing to Clinical Trials Arena